SAN DIEGO: GCS PR has been retained by Pfizer and Epicyte Pharmaceutical, which uses a patented technology to develop the production of human antibodies in plants for treating inflammatory and infectious diseases. The GCS team, led by Tom Gable and Jon Schmid, was retained by Pfizer to provide media relations for the May 1 opening of a new research center, Pfizer La Jolla.
Have you registered with us yet?
Register now to enjoy more articles and free email bulletinsRegister
Already registered?Sign in
Join a growing community of PRWeek comms professionals today
- Read more articles each month
- Sign up for free specialised news bulletins